Karen L. Zaderej - Net Worth and Insider Trading
Karen L. Zaderej Net Worth
The estimated net worth of Karen L. Zaderej is at least $21 Million dollars as of 2025-01-12. Karen L. Zaderej is the CEO of Axogen Inc and owns about 1,143,788 shares of Axogen Inc (AXGN) stock worth over $21 Million. Karen L. Zaderej is also the Director of EyePoint Pharmaceuticals Inc and owns about 16,500 shares of EyePoint Pharmaceuticals Inc (EYPT) stock worth over $137,610. Details can be seen in Karen L. Zaderej's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Karen L. Zaderej has not made any transactions after 2024-08-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Karen L. Zaderej
Karen L. Zaderej Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Karen L. Zaderej owns 3 companies in total, including Axogen Inc (AXGN) , Viveve Medical Inc (VIVE) , and EyePoint Pharmaceuticals Inc (EYPT) .
Click here to see the complete history of Karen L. Zaderej’s form 4 insider trades.
Insider Ownership Summary of Karen L. Zaderej
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AXGN | Axogen Inc | 2024-03-21 | director & CEO |
| VIVE | Viveve Medical Inc | 2018-09-13 | director |
| EYPT | EyePoint Pharmaceuticals Inc | 2024-08-19 | director |
Karen L. Zaderej Latest Holdings Summary
Karen L. Zaderej currently owns a total of 2 stocks. Among these stocks, Karen L. Zaderej owns 1,143,788 shares of Axogen Inc (AXGN) as of March 21, 2024, with a value of $21 Million and a weighting of 99.34%. Karen L. Zaderej also owns 16,500 shares of EyePoint Pharmaceuticals Inc (EYPT) as of August 19, 2024, with a value of $137,610 and a weighting of 0.66%.
Latest Holdings of Karen L. Zaderej
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AXGN | Axogen Inc | 2024-03-21 | 1,143,788 | 18.05 | 20,645,373 |
| EYPT | EyePoint Pharmaceuticals Inc | 2024-08-19 | 16,500 | 8.34 | 137,610 |
Holding Weightings of Karen L. Zaderej
Karen L. Zaderej Form 4 Trading Tracker
According to the SEC Form 4 filings, Karen L. Zaderej has made a total of 6 transactions in Axogen Inc (AXGN) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Axogen Inc is the sale of 39,280 shares on March 21, 2024, which brought Karen L. Zaderej around $301,670.
According to the SEC Form 4 filings, Karen L. Zaderej has made a total of 1 transactions in EyePoint Pharmaceuticals Inc (EYPT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in EyePoint Pharmaceuticals Inc is the acquisition of 12,500 shares on August 19, 2024, which cost Karen L. Zaderej around $99,750.
Insider Trading History of Karen L. Zaderej
- 1
Karen L. Zaderej Trading Performance
GuruFocus tracks the stock performance after each of Karen L. Zaderej's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Karen L. Zaderej is 9.41%. GuruFocus also compares Karen L. Zaderej's trading performance to market benchmark return within the same time period. The performance of stocks bought by Karen L. Zaderej within 3 months outperforms 5 times out of 8 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Karen L. Zaderej's insider trading performs compared to the benchmark.
Performance of Karen L. Zaderej
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 9.47 | | | | | |
| Relative Return to S&P 500(%) | 8.81 | | | | | |
Karen L. Zaderej Ownership Network
Ownership Network List of Karen L. Zaderej
Ownership Network Relation of Karen L. Zaderej
Karen L. Zaderej Owned Company Details
What does Axogen Inc do?
Who are the key executives at Axogen Inc?
Karen L. Zaderej is the director & CEO of Axogen Inc. Other key executives at Axogen Inc include Chief R&D Officer Angelo Scopelianos , VP & Clinical&Translational Sc Erick Wayne Devinney , and VP Operations Michael Patrick Donovan .
Axogen Inc (AXGN) Insider Trades Summary
Over the past 18 months, Karen L. Zaderej made 1 insider transaction in Axogen Inc (AXGN) with a net sale of 39,280. Other recent insider transactions involving Axogen Inc (AXGN) include a net sale of 42,343 shares made by Michael Patrick Donovan , a net sale of 25,000 shares made by Gregory Gene Freitag , and a net sale of 12,500 shares made by Peter J Mariani .
In summary, during the past 3 months, insiders sold 0 shares of Axogen Inc (AXGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 130,582 shares of Axogen Inc (AXGN) were sold and 30,000 shares were bought by its insiders, resulting in a net sale of 100,582 shares.
Axogen Inc (AXGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Axogen Inc Insider Transactions
Karen L. Zaderej Mailing Address
Above is the net worth, insider trading, and ownership report for Karen L. Zaderej. You might contact Karen L. Zaderej via mailing address: Axogen Inc., 13859 Progress Blvd, Suite 100, Alachua Fl 32615.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
